Healthcare >> CEO Interviews >> October 17, 2003
JAMES D. WOODWARD has been President and Chief Executive Officer of
Encelle, Inc. since 1996. Mr. Woodward has more than 22 years of
experience in the life-sciences industry, primarily in start-up and
development-stage companies. From 1981 to 1986, he was CFO of Advanced
Cardiovascular Systems, Inc., which was acquired by Eli Lilly and
Company in 1984 and is now known as Guidant Corporation. Mr. Woodward
was President & CEO of Cardiometrics from 1986 to 1990. Between 1991
and 1995 he was interim CEO in both start-up and turnaround situations
(Intella Systems and Aprex Corporation) as well as being an active
investor in early-stage life science companies. He was a co-founder of
Ventana Medical Systems, Interventional Technologies, and Accordant
Health Services. Mr. Woodward holds an A.B. in Economics from Princeton
University and a MBA from Stanford University Graduate School of
Business. Profile
technology and a brief history of the company?
Mr. Woodward: The technology was actually developed in the early days
